Ling JL, Bays DJ, Thompson GR III, Moshiri A, Mannis MJ.  Favorable Outcome in Coccidioides endophthalmitis – a Combined Medical and Surgical Treatment Approach.  Cornea.   2017 Nov;36(11):1423-1425.PMID:  28872517

Thompson GR III, Barker B, Wiederhold NP.  Large Scale Evaluation of in vitro Amphotericin B, Triazole, and Echinocandin activity against Coccidioides species from United States Institutions.  Antimicrobial Agents and Chemotherapy.  2017 April 61(4):e02634-16; 1-4

Thompson GR III, Blair J, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidari A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Johnson R.  Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.  Clinical Infectious Diseases.  Accepted for Publication.

Jiang G, Santos-Rocha C, Hirao L, Mendes E, Tang Y, Thompson GR III, Wong J, and Satya Dandekar.  HIV exploits anti-viral host innate GCN2-ATF4 signaling for establishing its own replication early in infection.  mBio.  May/June 2017;8(3):e01518-16; 1-16.   PMID:  28465428

Thompson GR III, Chang D, Wittenberg RR, McHardy I, Semrad A.  Posaconazole Induced Hypertension and Hypokalemia: In vivo 11β-hydroxysteroid dehydrogenase Inhibition.  Antimicrobial Agents and Chemotherapy.  2017 August 61(8):e00760-17; 1-4.  PMID:  28533238

Hansen, LM, Gideonsson, P, Canfield, DR, Boren T, Solnick, JV.  Dynamic Expression of the BabA Adhesin and its BabB Paralog During Helicobacter pylori Infection in Rhesus Macaques, Infect Immun, 2017, in press.

Kable, ME, Hansen,GLM, Styer, CM, Deck, SL, Rakhimova, O, Shevtsova, A, Eaton, KA, Martin, ME, Gideonsson, P, Borén , T, and Solnick, JV. Host Determinants of Expression of the Helicobacter pylori BabA Adhesin.  Scientific Reports, 2017, in press.

Draper, JL, Hansen, LM, Bernick, D, Abedrabbo, S, Underwood, JG, Kong, N, Huang, CB, Weiss, AM, Weimer, BC, van Vliet, AHM, Pourmand, N, Solnick, JV [co-corresponding author], Karplus, K, Ottemann, KM. Fallacy of the unique genome: Sequence diversity within single Helicobacter pylori strains.  mBio, 2017, 8:e02321-16.

Bugaytsova, J, Chernov, YA,  . . . Solnick, JV . . . and Boren, T. Adaption of Helicobacter pylori to Chronic Infection and Gastric Disease by pH-Responsive BabA Mediated Adherence.  Cell Host Microbe, 2017, 21:376-389.

Brown J. Confusion and seizures in a stem cell transplant recipient. Am J Transplant. 2017; 17(5):1418-20.

Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Wook-Chun T, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DMCorrection: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.  PLoS Pathog. 2017 May 3;13(5):e1006368. PMID: 28467485

Rockstroh JK, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Zhang-Roper R, Wang R, Pineda JA, Heera J.  Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial. Antivir Ther. 2017;22(3):263-269.

Wan D, Yang J, Mann S, Garcia JC, Troia-Cancio P, Yotter T, Pollard RB, Hammock BD, Asmuth DM. Impact of serum-derived bovine immunoglobulin (SBI) on vitamin D metabolite levels in subjects with HIV enteropathy measured by a novel sensitive method using mass spectrometry. In Abstracts for the 9th IAS Conference on HIV Pathogenesis, Treatment & Prevention. Paris, France. July 23-26, 2017. Abstract MOPEB0364.

Garrett KL, Mann S, Sainz-Costa T, Serrano-Villar S, Garcia JC, Troia-Cancio P, Li X-D, Pollard R, Yotter T, Kashuba ADM, Asmuth D. Exposure of Darunavir (DRV), Ritonavir (RTV), Emtricitabine (FTC), and Tenofovir (TFV) in Duodenal Tissue: Implications of Gastrointestinal (GI) Immune Reconstitution Among HIV-Infected Patients Undergoing Antiretroviral Treatment. In Abstracts for the 9th IAS Conference on HIV Pathogenesis, Treatment & Prevention. Paris, France. July 23-26, 2017. Abstract MOPEG0330.

Peginterferon α-2a for the treatment of HIV infection. Expert Opinion on Investigational Drugs. 25(2). David M Asmuth, MD; Netanya S Utay; Richard B Pollard, MD

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLOS Pathogens. 12(1):e1005381. Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, Netanya S. Utay, Tae-Wook Chun, Surinder Mann, Angela D. Kashuba, Basile Siewe, Anthony Albanese, Paolo Troia-Cancio, Elizabeth Sinclair, Anoma Somasunderam, Tammy Yotter, Steven G. Deeks, Alan Landay, Richard B. Pollard, Christopher J. Miller, Santiago Moreno, David M. Asmuth

Barrozo, RM, Hansen, LM, Lam, AM, Skoog, EC, Martin, ME, Cai, LP, Lin, Y, Latoscha, A, Suerbaum, S, Canfield, DR, and Solnick, JV.  CagY is an Immune-Sensitive Regulator of the Helicobacter pylori Type IV Secretion System.  Gastroenterology 2016;151:1164–1175.  [Featured on the Cover]

Skoog, EC, Deck, SL, Entwistle, HD, Hansen, LM, and Solnick, JV. Characterization of the Cag pathogenicity island in Helicobacter pylori from naturally infected rhesus macaques.  FEMS Microbiol Lett 2016, 363: 1-8.

Moonens, K, Gideonsson, . . .  Solnick, JV, and  T, Remut, H.  Structural Insight in Adaptive and Redox-sensitive ABO Glycan Binding by Helicobacter pylori.  Cell Host Microbe, 2016 Jan 13;19(1):55-66.

Serrano-Villar S, Sainz T, Ma Z-M, Utay NS, Chun T-W, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. Effects of Combined CCR5/Integrase Inhibitors-based Regimen on Mucosal Immunity and HIV Persistence in HIV-infected Patients Naïve to Antiretroviral Therapy. 2016 PLoS Pathogens. 12(1): e1005381. doi:10.1371/journal. ppat.1005381

Asmuth DM, Utay NS, Pollard RB. Pegylated Interferon alfa-2a for the Treatment of HIV Infection. Expert Opin Invest Drugs. 2016 Jan 4:1-9.

Taylor J, Carr-Lopez S, Robinson A, Malmstrom R, Duncan K, Maniar A, Del Re A, Carmichael J.  “Determinants of Treatment Eligibility in Veterans with Hepatitis C Viral Infection.”  Clin Ther 2016 Nov; 39(1) 130-137.

Nand P, Wilson MD, Cohen SH, Brown J. Curbing antimicrobial resistance: Do physicians receive adequate education about antibiograms? J Infect. 2016;72(1):127-9.

Bui C, Zhu E, Donnelley M, Wilson M, Morita M, Cohen SH, Brown J. Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infections. Am J Infect Control. 2016;44(12):1684-86.

Brown J. Can multiplex PCR testing improve the diagnosis and treatment of community-acquired pneumonia? Review of Gadsby et al. Clin Infect Dis. 2016; 62:817-823. Infectious Diseases Society of America Journal Club. April 2016. http://newsmanager.commpartners.com/idsa/issues/2016-04- 21/24.html

Maertens JA, Raad I, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz W, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Supparatpinyo K, Thompson GR III, Lee M, Maher R, Schmitt-Hofmann AH, Zeiher B, Ullmann AJ.  Isavuconazole versus Voriconazole for Primary Treatment of Invasive Mold Disease Caused by Aspergillus and Other Filamentous Fungi (The SECURE study).  Lancet. 2016 Feb 20;387(10020):760-9.  PMID:  26684607

Stockamp N, Thompson GR III.  Coccidioidomycosis.  Infectious Disease Clinics of North America.  2016 Mar;30(1):229-46.  PMID:  26739609

Cadena J, Thompson GR III, Patterson TF.  Invasive Aspergillosis:  Current Strategies for Diagnosis and Management.  Infectious Disease Clinics of North America.  2016 Mar;30(1):125-42.  PMID:  26897064

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR III, Alangaden GJ, Brown JM, Fredricks JN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild J, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher R, Zeiher B, Vehreschild MJGT, for the VITAL and FungiScope Mucormycosis Investigators. Isavuconazole Treatment for Mucormycosis.  The Lancet Infectious Disease.  2016  Jul;16(7):828-37.  PMID:  26969258

Engelthaler DM, Roe CC, Hepp, CM, Teixeira M, Driebe EM, Schupp JM, Gade L, Waddell V, Komatsu K, Arathoon E, Logemann H, Thompson GR III, Chiller T, Barker B, Litvintseva AP, Keim P.  Coccidioides whole population genome SNP analysis reveals local population structure and patterns of hemispheric dispersal.  Manuscript accepted for publication to mBio.  2016 Apr 26;7(2):e00550-16. PMID:  27118594

Schwartz IS, Kenyon C, Thompson GR III.  Endemic Mycoses:  What’s new about old diseases?  Current Clinical Microbiology Reports.  2016 3:71–80

Thompson GR III, Rendon A, Santos R, Queiroz-Telles F,  Ostrosky-Zeichner L, Zeiher B,  Maher R, Lee M, Kovanda L, Vazquez J, Cornely OA, Perfect JR.  Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.  Clinical Infectious Diseases. 2016 Aug 1;63(3):356-62.  PMID:  27169478

Donnelley MA, Zhu ES, Thompson GR III.  Isavuconazole in the Treatment of Invasive Aspergillosis and Mucormycosis Infections.  Infection and Drug Resistance.  2016 Jun 2;9:79-86. PMID:  27330318

Patterson TF, Thompson GR III, Denning D, Fishman F, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young J, Bennett JE.  Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.  Clinical Infectious Diseases.  2016 Aug 15;63(4):433-42.  PMID:  27481947

Patterson TF, Thompson GR III, Denning D, Fishman F, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young J, Bennett JE.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.    PMID:  27365388

Vishkautsan P, Papich MG, Thompson GR III, Sykes JE.  Pharmacokinetics of voriconazole after intravenous and oral administration to healthy cats.  American Journal of Veterinary Research.  2016 Sep;77(9):931-9.  PMID:  27580104

Sykes JE, Hodge G, Gelli A, Yang ML, Thompson GR III.  In vivo Development of Fluconazole Heteroresistance in Cryptococcus gattii.  Medical Mycology.  2017 Jun 1;55(4):396-401.  PMID:  28339594

Stewart ER, Thompson GR III.  Treatment of Primary Pulmonary Aspergillosis:  An assessment of the evidence.  Journal of Fungi.  2016 2(25):1-9.

Stewart ER, Thompson GR III.  Update on the Epidemiology of Coccidioidomycosis.  Current Fungal Infection Reports.  2016 Oct 10:141-146.

Lung Microbiomes – new frontiers? American Journal of Respiratory and Critical Care Medicine. 191(8):870-1. DeRiemer K, Thompson GR III

Call for a California Coccidioidomycosis Consortium to Face the Top Ten Challenges Posed by a Recalcitrant Regional Disease.  Mycopathologia. 179(1-2):19. Thompson GR III, Stevens DA, Clemons KV, Fierer J, Johnson RH, Sykes J, Rutherford G,Peterson M, Taylor JW, Chaturvedi V.

Determination of HIV-1 coreceptor tropism using proviral  DNA in women  before and after viral suppression. AIDS Research and Therapy. 12:11. Baumann R, Rogers A, Hamdan H, Burger H, Weiser B, Gao W, Anastos K, Young M, Meyer WA III, Pesano R, Kagan R

Histoplasma, Blastomyces, Coccidioides and other dimorphic fungi causing systemic mycoses.  Manual of Clinical Microbiology (ASM Press) 11th Ed.  In press 2015, Thompson GR III, Gomez BL. Available at: http://www.asmscience.org/content/book/10.1128/9781555817381

Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection: A Randomized Clinical TrialJournal of the American Medical Association. 313(17):1719-1727. Dale N. Gerding, MD, Thomas Meyer, MD, Christine Lee, MD, Stuart H. Cohen, MD, Uma K. Murthy, MD, Andre Poirier, MD, MSc, Trevor C. Van Schooneveld, MD, Darrell S. Pardi, MD, MS, Antonio Ramos, MD, Michelle A. Barron, MD, Hongzi Chen, PhD, Stephen Villano, MD

Curbing antimicrobial resistance: Do physicians receive adequate education about antibiograms? Journal of Infection. 72(1):127-129. Priyasheelta Nand, MD; Machelle D. Wilson; Stuart H. Cohen, MD; Jennifer Brown, MD.

In vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy. Medical Mycology. 53(7):749-753 Greg Hodge; Stuart H. Cohen, MD; George R. Thompson III, MD

Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. Journal American Medical Association Internal Medicine. 175(11):1792-1801 Christopher R. Polage, MD, MAS; Clare E. Gyorke, BS; Michael A. Kennedy, BS; Jhansi L. Leslie, BS; David L. Chin, PhD; Susan Wang, BS; Hien H. Nguyen, MD, MAS; Bin Huang, MD, PhD; Yi-Wei Tang, MD, PhD; Lenora W. Lee, MD; Kyoungmi Kim, PhD; Sandra Taylor, PhD; Patrick S. Romano, MD, MPH; Edward A. Panacek, MD, MP; Parker B. Goodell, BS, MPH; Jay V. Solnick, MD, PhD; Stuart H. Cohen, MD

Swabbing Surgical Sites Does Not Improve the Detection of Staphylococcus aureus Carriage in High-Risk Surgical Patients. Surgical Infections. 16:523-525 Jennifer Brown,MD; Chin-Shang Li, PhD; Mauro Giordani, MD; Kiarash Shahlaie, MD, PhD; Eric O. Klineberg, MD, MS; Joanna R. Tripet-Diel, Marie S. Ihara, and Stuart H. Cohen, MD

Treatment of Cytomegalovirus Retinitis With Cytomegalovirus‐Specific T‐Lymphocyte Infusion. Ophthalmic Surg Lasers Imaging Retina. 46(1):80–82 Mrinali Patel Gupta, MD; Peter Coombs, MD; Susan E. Prockop, MD; Aisha A. Hasan, MD; Ekatarina Doubrovina, MD, PhD; Stuart H. Cohen, MD; Susanna S. Park, MD PhD; Szilárd Kiss, MD

Stem cell transplantation in the context of HIV – how can we cure HIV infection? Expert Review of Clinical Immunology. 10(1):107-116. Gerhard Bauer, MD; Joseph S Anderson, MD

Safety and Efficacy of a tCD25 Preselective Combination Anti-HIV Lentiviral Vector in Human Hematopoietic Stem and Progenitor Cells. Stem Cells. 33(3):870-879. Sharlie L. Barclay; Yimin Yang; Siruo Zhang; Ryan Fong; Alfonso Barraza; Jan A. Nolta, PhD; Bruce E. Torbett; Mehrdad Abedi, MD; Gerhard Bauer, BS; Joseph S. Anderson, PhD.

Hallmarks of HIV-1 pathogenesis are modulated by Nef’s Secretion Modification Region. Journal of AIDS & Clinical Research. 6(7):476. Kateena Addae Konadu, MD, PhD; Joseph S Anderson, PhD; Ming-Bo Huang, MD; Syed A Ali, MD; Michael D Powell, Francois Villinger, PhD; Vincent C Bond PhD.

C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings. PloS One. 10(2):e0117424. Mark W. Tenforde1, Nikhil Gupte1, David W. Dowdy, David M. Asmuth, Ashwin Balagopal1, Richard B. Pollard, Patcharaphan Sugandhavesa, Javier R. Lama, Sandy Pillay, Sandra W. Cardoso, Jyoti Pawar, Breno Santos, Cynthia Riviere, luthando Mwelase11, Cecilia Kanyama, Johnstone Kumwenda, James G. Hakim, Nagalingeswaran Kumarasamy, Robert Bollinger, Richard D. Semba1, Thomas B. Campbell, Amita Gupta1, for the ACTG PEARLS and NWCS 319 Study Group

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case–Cohort Study. Journal of Acquired Immune Deficiency Syndromes. 70(2):163-171. Ashwin Balagopal, MD, David M. Asmuth, MD, Wei-Teng Yang, MD, Thomas B. Campbell, MD, Nikhil Gupte, PhD, Laura Smeaton, MS, Cecilia Kanyama, MD, Beatriz Grinsztejn, MD, PhD, Breno Santos, MD, Khuanchai Supparatpinyo, MD, Sharlaa Badal-Faesen, MBBCh, Javier R. Lama, MD, MPH, Umesh G. Lalloo, MBChB, MD, Fatima Zulu, MSc, Jyoti S. Pawar, MBBS, Cynthia Riviere, MD, Nagalingeswaran Kumarasamy, MD, James Hakim, MD, Xiao-Dong Li, MD, PhD, Richard B. Pollard, MD, Richard D. Semba, MD, MPH, David L. Thomas, MD, MPH, Robert C. Bollinger, MD, MPH, Amita Gupta, MD, the ACTG PEARLS and NWCS 319 Study team

Coccidioides Endospores and Spherules Draw Strong Chemotactic, Adhesive, and Phagocytic Responses by Individual Human Neutrophils. PloS One. 10(6):e0129522. Cheng-Yuk Lee, George R. Thompson III, Christine J. Hastey, Gregory C. Hodge, Jennine M. Lunetta, Demosthenes Pappagianis, Volkmar Heinrich

Mycotic Infections Acquired outside Areas of Known Endemicity, United States. Emerging Infectious Diseases. 21(11):1935-941. Kaitlin Benedict, George R. Thompson III, Stan Deresinski, Tom Chiller

The safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Infect Dis. 14(4): 291-300. Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B, Lazzarin A, Gatell J, Ellefsen-Lavoie K, Podzamczer D, Van Lunzen J, Arastéh K, Schürmann D, Clotet B, Hardy D, Mitsuyasu R, Moyle G, Plettenberg A, Fisher M, Fätkenheuer G, Fischl M, Taiwo B, Baksaas I, Jolliffe D, Persson S, Jelmert Ø, Hovden A-O, Sommerfelt MA, Wendel-Hansen V, Sørensen B. 

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection. JAMA. 312(4): 353-361. Sulkowski MS, Naggie S, Lalezari J, Fessel WJ, Mounzer W, Shuhart M, Luetkemeyer AF, Asmuth D, Gaggar A, Ni L, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Rodriguez-Torres M, Dieterich D.

Clinical and Immunologic Predictors of Death During an Acute Opportunistic Infection: Results from ACTG A5164. HIV Clin Trials. 15(4): 133-139. Grant PM, Komarow L, Sanchez A, Sattler FR, Asmuth DM, Pollard RB, Zolopa AR. 

Managing an outpatient parenteral antibiotic therapy team: challenges and solutions. Therapeutics and Clinical Risk Management. 10: 459-465. Halilovic J, Christensen C, and Nguyen HH.

Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii complex by the CLSI Broth Microdilution Method (M27-A3 document): A Multicenter Study. Antimicrobial Agents and Chemotherapy. 179(1):1-9. Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Guinea J, Hagen F, Meis J, Thompson GR III, Turnidge J. 

The Habit Tic: onychotillomaniaJournal of General Internal Medicine. 30(2):264. Najafi S, Aronowitz, P, Thompson GR III

Fungal infections of the skin and nail: new treatment optionsExpert Review of Anti-infective Therapy.  (11):1389-405.Eldridge M, Chambers CJ, Sharon VR, Thompson GR III

Valley Fever: Finding new places for an old disease: Coccidioides immitis found in Washington State soil associated with recent human infectionClinical Infectious Diseases. 60(1):e1-3. Litvintseva AP, Marsden-Haug N, Hurst S, Hill H, Gade L, Engelthaler DM, Driebe E, Roe C, Keim P, Ralston C, Wohrle R, Goldoft M, Thompson GR III, Chiller T, Brandt M. 

Cryptococcus gattii in North American Pacific Northwest:  whole population genome analysis provides insights into species evolution and dispersal. mBio. 5(4). Engelthaler DM, Hicks N, Gillece J, Roe C, Schupp JM, Driebe EM, Gilgado F, Carriconde F, Trilles L, Firacative C, Ngamskulrungroj P, Castaneda E, Lazera MDS, Melhem M, Perez-Bercoff A, Huttlley G, Sorrell T, Voelz K, My RC, Fisher M, Thompson GR III, Lockhart S,  Keim P, Meyer W. 

Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloproteasemBio.  5(3):e01101-14.Vu K, Tham R, Uhrig JP, Thompson GR III, Na Pombejra S, Jamklnag M, Mautos JM, Gelli A. 

Reactivation of HIV latency by a newly modified Ingenol derivative via PKCδ-NFκB signaling.  AIDS. 28(11):1555-66. Jiang G, Mendes EA, Kaiser P, Sankaran-Walters S, Tang Y, Weber MG, Melcher GP, Thompson GR III, Tanuri A, Pianowski LF, Wong JK, Dandekar S. 

Phenotypic Differences of Cryptococcus genotypes:  implications for virulence in a Drosophila model of infectionInfection and Immunity. 82(7):3058-3065. Thompson GR III, Albert N, Hodge G, Wilson MD, Sykes JE, Bays DJ, Firacative C, Meyer W, Kontoyiannis DP. 

Antifungal Drug Susceptibility and Phylogenetic Diversity Among Cryptococcus Isolates from Dogs and Cats in North AmericaJournal of Clinical Microbiology. 52(6):2061-70.  Singer LM, Meyer W, Firacative C, Thompson GR III, Samitz E, Sykes JE.

Failure of Clindamycin to Eradicate Infection with Beta-Hemolytic Streptococci Inducibly Resistant to Clindamycin in an Animal Model and in Human InfectionsAntimicrobial Agents and Chemotherapy. 58(3):1327-31. Lewis JS II, Lepak AJ, Thompson GR III, Craig WA, Andes DR, Sabol-Dzintars KE, Jorgensen JH. 

Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's. Virology. 449: 181-9.  Weber, S, Weiser, B, Kemal, KS, Burger, H, Ramirez, CM, Korn, K, Anastos, K, Kaul, R, Kovacs, C, Doerfler, W.

 A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects. AIDS research and therapy. 11: 14. Brown, J, Burger, H, Weiser, B, Pollard, RB, Li, XD, Clancy, LJ, Baumann, RE, Rogers, AA, Hamdan, HB, Pesano, RL, Kagan, RM.

Antifungal Drugs: Mechanisms of Action, Drug Resistance, Susceptibility Testing, and Assays of Activity in Biological Fluids.  In:  Antibiotics in Laboratory Medicine 6th Ed.  Lippincott Williams and Wilkins,  Thompson GR III, Patterson TF.

The evolving landscape of healthcare-associated infections: Recent advances in prevention and a road map for research. Infect Control Hosp Epidemiol 35:480-493. Safdar N, Anderson DJ, Braun BI, Carling P, Cohen S, Donskey C, Drees M, Harris A, Henderson DK, Huang SS, Juthani-Mehta M, Lautenbach E, Linkin DR, Meddings J, Miller LG, Milstone A, Morgan D, Sengupta S, Varman M, Yokoe D, Zerr DM

Cutaneous Manifestations of Infection in Returning TravelersCurrent Infectious Disease Report. 16:426. Matthew Eldridge, MD; Stuart Cohen, MD

Canine Epidermal Neural Crest Stem Cells: Characterization and Potential as Therapy Candidate for a Large Animal Model of Spinal Cord Injury. Stem Cells Translational Medicine. 3:334-345 Barbara Gericota; Joseph S. Anderson, PhD; Gaela Mitchell; Dori L. Borjesson; Beverly K. Sturges; Jan A. Nolta, PhD; Maya Sieber-Blum

 

 

HIV Disease Activity as a Modulatory of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels.  Arterioscler Thromb Vasc Biol, 33(2): 387-392. Byambaa A, Nuerdem A, Zhang W, Asmuth DM, Abbuthalha A, Li X-D, Dotterweich W, Pollard RB, Berglund L.

Impact of Highly Active Antiretroviral Therapy Initiation on CD4+ T-cell Repopulation in Duodenal and Rectal Mucosa. AIDS. 27(6): 867-877. Hayes TL, Asmuth DM, Critchfield JW, Knight TH, McLaughlin BE, Yotter T, McConnell DH, Garcia J-C, Pollard RB, Shacklett BL.

Oral Serum-Derived Bovine Immunoglobulin Improves Duodenal Immune Reconstitution and Absorption Function in Patients with HIV EnteropathyAIDS. 27(14): 2207-2217 Asmuth DM, Ma Z-M, Albanese A, Sandler NG, Devaraj S, Knight TH, Flynn NM, Yotter T, Garcia J-C, Tsuchida E, Wu T-T, Douek DC, Miller CJ.

HIV Infection and Atherosclerosis: Evaluating the Drivers of Inflammation. European Journal of Preventive Cardiology. 20(5): 720-728. Maniar A, Ellis CE, Asmuth D, Pollard RB, Rutledge J.

Safety, Tolerability and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV Infected Patients Receiving Combination Antiretroviral Therapy. Results of the ACTG 5176 Trial. 64(4): 351-359. Rodriguez B, Asmuth DM, Matining R, Spritzler J, Jacobson J, Mailliard R, Li X-D, Read S, Martinez A, Tenorio A, Lori F, Lisziewicz J, Yesmin S, Rinaldo CR, Pollard R.

Teaching Neuroimages: Fungus in the brain: Coccidioidomycosis meningoencephalitis. Neurology. 80: e82 Goldenholz DM, Mehra N, Dahlin B, Cohen SH, and Wheelock VL. 

Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest. 143(3): 776-781. Thompson GR, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe EM, Davis M, Libke R, Cohen SH, and Pappagianis D.

Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection. Medical Mycology, 51(3): 319-323.  Thompson GR 3rd, Bays D, Taylor SL, Cohen SH, and Pappagianis D

Discord among performance measures for central line-associated bloodstream infection. Infection Control and Hospital Epidemiology, 34(2): 176-183. Publications Page 8 of 21 Tehrani DM, Russell D, Brown J, Boynton-Delahanty K, Quan K, Gibbs L, Braddock G, Zaroda T, Koopman M, Thompson D, Nichols A, Cui E, Liu C, Cohen S, Rubin Z, Pegues D, Torriani F, Datta R, and Huang SS.

 Community-Acquired Clostridium difficile Infection: An Emerging Problem. Current Emergency and Hospital Medicine Reports, 1(3): 149-153. Lee L and Cohen SH.

Fatal transplant-associated west nile virus encephalitis and public health investigation-California, 2010. Transplantation, 96(5): 463-468. Rabe IB, Schwartz BS, Farnon EC, Josephson SA, Webber AB, Roberts JP, de Mattos AM, Gallay BJ, van Slyck S, Messenger SL, Yen CJ, Bloch EM, Drew CP, Fischer M, Glaser CA, and Cohen SH (in the WNV Transplant Investigation Team).

Deafness Among Physicians and Trainees: A National Survey. Academic Medicine, 88(2): 224-232. Moreland C, Latimore D, Sen A, Arato N, Zazova P.

From vital signs to clinical outcomes for patients with sepsis: a machine learning basis for a clinical decision support system. Journal of the American Medical Informatics Association, epub ahead of print.. Gultepe E, Green JP, Nguyen H, Adams J, Albertson T, Tagkopoulos I. 

 HIV+ Viremic Slow Progressors Maintain Low Regulatory T-Cell Numbers in Rectal Mucosa but Exhibit High T-cell Activation. AIDS Research and Human Retroviruses, 29(1): 172-177. Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks S, Shacklett BL.

Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis. AIDS, 27(7): 1193–1194. Allen ME, Brown J, Karakas SE, and Pollard RB.

Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. AIDS, 27(10): 1563-1571. Kalayjian RC, Spritzler J, Matining RM, Fiscus SA, Gross BH, Francis IR, Pollard RB, Lederman MM, and Landay A. 

HIV infection enhances the responsiveness of antigen presenting cells to commensal lactobacillus. PLoS ONE, 8(8): e72789. Publications Page 29 of 78  Nagy LH, Grishina I, Macal M, Hirao LA, Hu WK, Sankaran-Walters S, Gaulke CA, Pollard RB, Brown J, Suni M, Baumler AJ, Ghanekar S, Marco ML,  Dandekar S. Chronic

Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial. JAIDS, 64(4): 351-359. Rodriguez B, Asmuth DM, Matining RM, Spritzler J, Jacobson JM, Mailliard RB, Li XD, Martinez AI, Tenorio AR, Lori F, Lisziewicz J, Yesmin S, Rinaldo CR, and Pollard RB

Evaluation of fecal C. difficile load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi. Journal of Clinical Microbiology. 51: 278-780. Gyorke, C, Wang, S, Leslie, J, Cohen, S, Solnick, JV, Polage, CR.

 Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathogens. 2(e1003189). Barrozo, RM, Cooke, CL, Hansen, LM, Lam, AM, Gaddy, JA, Johnson, EM, Cariaga, TA, Suarez, G, Peek, RM Jr, Cover, TL, and Solnick, JV.

Biomarkers of Helicobacter pyloriassociated gastric cancer.  Gut Microbes. 4(6). Cooke, CL, Torres, J, Solnick, JV.

Amphotericin B-impregnated Bone Cement to Treat Refractory Coccidioidal Osteomyelitis. Antimicrobial Agents and Chemotherapy. 57(12):6341-3.  Zhu ES, Thompson GR III, Kreulen C, Giza E. 

Management of an Outbreak:  Real-World experience in the midst of an Exserohilum meningitis outbreak. Journal of the American Medical Association309(23):2493-5. Thompson GR III, Kontoyiannis DP, Patterson TF

Coccidioidomycosis: epidemiology. Clinical Epidemiology. 5:185-97. Brown J, Benedict K, Park BJ, Thompson GR III

Routine CSF Analysis in Coccidioidomycosis is Not Required. PLOS One.  8(5):e64249; 1-5.  Thompson GR III, Wang S, Bercovitch R, Bolaris M, Akker DVD, Taylor S, Lopez R, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B. 

Coccidioidomycosis Acquired in Washington State. Clinical Infectious Diseases. 56(6):847-50.  Marsden-Haug N, Goldoft M, Ralston C, Limaye AP, Chua J, Hill H, Jecha L, Thompson GR III, Chiller T. 

Pleural Effusions Caused by Coccidioidomycosis:  ADA levels, serologic parameters, culture results and PCR testingCHEST.  143(3):776-81. Thompson GR III, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe EM, Davis M, Libke R, Cohen SH, Pappagianis D.

Fungal Disease of the Nose and Sinuses: An Updated Overview Current Allergy and Asthma Reports.  13(2):152-61.  Chang C, Gershwin E, Thompson GR III.

Association Between Serum 25-Hydroxyvitamin D Level and Type of Coccidioidal InfectionMedical Mycology. 51(3):319-23. Thompson GR III, Bays DJ, Taylor SL, Cohen SH, Pappagianis D. 

The S40 residue in HIV-1 Gag p6 impacts local and distal budding determinants, revealing additional late domain activities. Retrovirology. 10: 143. Watanabe, SM, Chen, MH, Khan, M, Ehrlich, L, Kemal, KS, Weiser, B, Shi, B, Chen, C, Powell, M, Anastos, K, Burger, H, Carter, CA.

Molecular epidemiology of HIV type 1 subtypes in Rwanda. AIDS research and human retroviruses. 29(6): 957-62. Kemal, KS, Anastos, K, Weiser, B, Ramirez, CM, Shi, Q, Burger, H.

Coccidioidomycosis. Medscape Reference. Updated September 13, 2013. Hospenthal DR, Thompson GR III, Oppenheimer AP, Arsura EL. Available at: http://emedicine.medscape.com/article/215978-clinical

Fungi. APIC Text of Infection Control and Epidemiology 4th Ed.  In press. 2014 Cadena J, Thompson GR III, Patterson TF. Available at: http://apic.org/APICStore/Products/Product?id=SLSTXT14

The Epidemiology and Significance of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy. AIDS Research and Treatment. Vol. 2012, Article ID 262471, 5 pages. doi:10.1155/2012/262471. PMID: 22970352   Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Thompson GR III, Vallor AC, Redding SW, Patterson TF.

Serum (1®3)-β-D-Glucan Measurement in Coccidioidomycosis. Journal of Clinical Microbiology. Sep;50(9):3060-2. PMID: 22692738 Thompson GR III, Bays DJ, Johnson SM, Cohen, SH, Pappagianis D, Finkelman MA. D.

Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complement Altern Med.Jun 29;12(1):84.Schunter M, Chu H, Hayes TL, McConnell D, Crawford SS, Luciw PA , Bengmark S, Asmuth DM, Brown J, Bevins CL, Shacklett BL, Critchfield JW.

Thompson GR III, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill DR, Patterson TF.  A Murine Model of Cryptococcus gattii Meningoencephalitis.  Journal of Antimicrobial Chemotherapy.  2012 Jun;67(6):1432-8.  PMID:  22378683

Su H, Thompson GR III, Cohen SH.  Hepatic Mucormycosis with Abscess Formation.  Diagnostic Microbiology and Infectious Disease.  2012 Jun;73(2):192-4.  PMID:  22502961

Thompson GR III, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA.  D.  Serum (13)-β-D-Glucan Measurement in Coccidioidomycosis.  Journal of Clinical Microbiology.  2012 Sep;50(9):3060-2.  PMID:  22692738

Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Thompson GR III, Vallor AC, Redding SW, Patterson TF.  The Epidemiology and Significance of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy.   AIDS Research and Treatment.   2012;2012:262471.  PMID:  22970352